The Latest Breaking News from Accolade

Accolade has invested in top crypto venture firms from a16z to Haun.

Free Stars: Children of Infinity is Star Control 3 in all but name, and it managed to smash a $100,000 Kickstarter goal in under 3 hours

Wine prices have plunged due to an oversupply in the country and now growers are being offered financial incentives to switch varieties or mothball their vines. Some, however, are simply ripping their vines out of the ground.

Needham analyst Ryan MacDonald reiterated a Buy rating on Accolade, Inc (NASDAQ:ACCD) with a price target of $12. Following a problematic 4QF22, he noted that Accolade bounced back nicely in 1QF23 as the company beat management's initial outlook for FY23 revenue and adjusted EBITDA.  While early in the selling season, ACCD won more new business in 1QF23 than…

Over the past 3 months, 10 analysts have published their opinion on Accolade (NASDAQ:ACCD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Accolade Inc (NASDAQ:ACCD) reported first-quarter revenue growth of 44% year-over-year to $85.5 million, beating the consensus of $81.97 million. EPS was $(4.92), compared to $(0.84) in 1Q22. Adjusted gross profit increased by 63% Y/Y to $39 million, and margin expanded by 545 bps to 45.6%. Adjusted EBITDA loss widened to $(15.4) million…

Accolade (NASDAQ:ACCD) is set to give its latest quarterly earnings report on Thursday, 2022-06-30. Here's what investors need to know before the announcement. Analysts estimate that Accolade will report an earnings per share (EPS) of $-0.66.

 

Accolade's (NASDAQ:ACCD) short percent of float has fallen 9.9% since its last report. The company recently reported that it has 4.30 million shares sold short, which is 7.74% of all regular shares that are available for trading.